• Title of article

    A Case of Aripiprazole-Induced Tardive Dyskinesia withDramatic Evolution

  • Author/Authors

    Heitzmann, Edwige NorthAlsaceMentalHealthClinic (EtablissementPublicdeSant ́e Alsace Nord (EPSAN) - Brumath, France , Javelot, Hervé NorthAlsaceMentalHealthClinic (EtablissementPublicdeSant ́e Alsace Nord (EPSAN) - Brumath, France , Weiner, Luisa Psychiatry Department - University Hospital of Strasbourg - Strasbourg, France , Michel, Bruno OMEDIT Alsace - Facult ́e de Pharmacie-Laboratoire HuManiS (EA 7308) - Service Pharmacie-CHRU de Strasbourg - Strasbourg, France

  • Pages
    4
  • From page
    1
  • To page
    4
  • Abstract
    Aripiprazole is reported to be a good clinical safety profile antipsychotic. However, recent data suggest that the risk of tardivedyskinesia could be higher than initially thought. We report the case of aripiprazole-induced tardive dyskinesia with dramaticevolution in a patient with several risk factors, including older age and exposure to antipsychotic over a period longer than sixmonths. This case and its dramatic evolution, associated with other cases recently published, suggest reconsidering the real risk oftardivedyskinesiaassociatedwitharipiprazole,particularlyintheelderly
  • Keywords
    Aripiprazole-Induced Tardive Dyskinesia , Dramatic Evolution , Second-generation antipsychotics (SGAs)
  • Journal title
    Case Reports in Psychiatry
  • Serial Year
    2016
  • Full Text URL
    downloads.hindawi.com/journals/crips/2016/7031245.pdf
  • Record number

    2607338

    • Link To Document
    https://search.isc.ac/dl/search/defaultta.aspx?DTC=10&DC=2607338